Chemotherapy with bevacizumab for metastatic colorectal cancer: a retrospective review of 181 Japanese patients

Author： Saito Seiya   Hayashi Naoko   Sato Nobutaka   Iwatsuki Masaaki   Baba Yoshifumi   Sakamoto Yasuo   Miyamoto Yuji   Watanabe Masayuki   Yoshida Minoru   Sakai Kenji   Katsumori Takashi   Katahuchi Shigeru   Shigaki Nobuyuki   Yamada Kazutaka   Kimura Masami   Tanigawa Tomio   Takano Sadamu   Kuramoto Masafumi   Baba Hideo  

Publisher： Springer Publishing Company

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.18, Iss.4, 2013-08, pp. : 689-695

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patients

By Ogawa Kohei   Ueno Takao   Kato Ken   Nishitani Hitoshi   Akiyoshi Kohei   Iwasa Satoru   Nakajima Takako   Hamaguchi Tetsuya   Yamada Yasuhide   Hosokawa Ayumu   Sugiyama Toshiro   Shimada Yasuhiro  

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 1020-1024

Springer Publishing Company

Access to resources Recommend Favorite

Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice

By Rossi Luigi   Veltri Enzo   Zullo Angelo   Zoratto Federica   Colonna Maria   Di Seri Marisa   Longo Flavia   Mottolese Marcella   Giannarelli Diana   Ruco Luigi   Romiti Adriana   Barucca Viola   Adua Daniela   Tomao Silverio  

Future Oncology, Vol. 8, Iss. 9, 2012-09 ,pp. : 1193-1197

Future Medicine

Access to resources Recommend Favorite

CEA and CA19.9 as Early Predictors of Progression in Advanced/Metastatic Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy and Bevacizumab

By Petrioli Roberto   Licchetta Antonella   Roviello Giandomenico   Pascucci Alessandra   Francini Edoardo   Bargagli Gianluca   Conca Raffaele   Miano Salvatora Tindara   Marzocca Giuseppe   Francini Guido    

Cancer Investigation, Vol. 30, Iss. 1, 2012-01 ,pp. : 65-71

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients

By            

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1295-1300

Science Publishers

Access to resources Recommend Favorite

FOLFIRI plus bevacizumab as a first-line treatment for Japanese patients with metastatic colorectal cancer: a JACCRO CC-03 multicenter phase II study

By Kochi Mitsugu   Akiyama Yuji   Aoki Tatsuya   Hagiwara Ken   Takahashi Takao   Hironaka Katsuji   Teranishi Futoshi   Osuka Fumihiko   Takeuchi Masahiro   Fujii Masashi   Nakajima Toshifusa  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1097-1102

Springer Publishing Company

Access to resources Recommend Favorite